• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于磁诱导的用于检测 Tau 蛋白的膜敏化生物传感器。

Membrane sensitization biosensor based on magnetic inducing for Tau protein detection.

作者信息

Wang Haoyu, Wang Biaobiao, Bai Jinsuo, Yao Penglong, Guo Xing, Ge Yang, Sang Shengbo, Dong Xiushan, Dong Zhao

机构信息

Shanxi Key Laboratory of Artificial Intelligence & Micro Nano Sensors, Taiyuan University of Technology, Taiyuan, 030024, China.

Key Lab of Advanced Transducers and Intelligent Control System of the Ministry of Education, Taiyuan University of Technology, Taiyuan, 030024, China.

出版信息

Mikrochim Acta. 2025 Aug 14;192(9):590. doi: 10.1007/s00604-025-07386-5.

DOI:10.1007/s00604-025-07386-5
PMID:40804145
Abstract

Surface stress-based biosensors exhibit excellent performance in detecting high concentrations of biomolecules; however, their sensitivity at low concentrations is often limited by insufficient deformation caused by weak binding-induced signals. To overcome this limitation, we propose an actively driven biosensor based on a multilayered heterogeneous magnetic film (PDMS/NiFe/FeMn), which achieves synergistic amplification of surface stress and geometric deformation under magnetic field modulation, thereby breaking through the sensitivity bottleneck of conventional designs. The sensor architecture leverages the high magnetic permeability of NiFe and the magnetostrictive effect of FeMn to construct a magneto-mechanical coupling interface: the NiFe layer efficiently transduces magnetic field energy, while the FeMn layer actively deforms to amplify the surface stress generated by target binding (Tau protein). A flexible PDMS substrate further releases mechanical strain, establishing a dual amplification mechanism of "biorecognition-magnetically driven deformation-electrical signal output." The experimental results show that the detection limit of this sensor for the Alzheimer's disease biomarker Tau protein is as low as 25.7 pM. Compared with self-made non-magnetic sensors, the sensitivity has been significantly improved, and it maintains stable performance in artificial cerebrospinal fluid. This approach, based on active signal amplification through heterogeneous magnetic film coupling, offers a new paradigm for the ultrasensitive detection of low-abundance biomarkers in complex biofluids and holds significant promise for the early diagnosis of neurodegenerative diseases.

摘要

基于表面应力的生物传感器在检测高浓度生物分子方面表现出色;然而,它们在低浓度下的灵敏度往往受到弱结合诱导信号引起的变形不足的限制。为了克服这一限制,我们提出了一种基于多层异质磁性薄膜(PDMS/NiFe/FeMn)的主动驱动生物传感器,该传感器在磁场调制下实现了表面应力和几何变形的协同放大,从而突破了传统设计的灵敏度瓶颈。该传感器架构利用NiFe的高磁导率和FeMn的磁致伸缩效应构建了一个磁机械耦合界面:NiFe层有效地转换磁场能量,而FeMn层主动变形以放大由目标结合(Tau蛋白)产生的表面应力。柔性PDMS基板进一步释放机械应变,建立了“生物识别-磁驱动变形-电信号输出”的双重放大机制。实验结果表明,该传感器对阿尔茨海默病生物标志物Tau蛋白的检测限低至25.7 pM。与自制的非磁性传感器相比,灵敏度有了显著提高,并且在人工脑脊液中保持稳定的性能。这种基于异质磁性薄膜耦合的主动信号放大方法为复杂生物流体中低丰度生物标志物的超灵敏检测提供了一种新范式,对神经退行性疾病的早期诊断具有重要意义。

相似文献

1
Membrane sensitization biosensor based on magnetic inducing for Tau protein detection.基于磁诱导的用于检测 Tau 蛋白的膜敏化生物传感器。
Mikrochim Acta. 2025 Aug 14;192(9):590. doi: 10.1007/s00604-025-07386-5.
2
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
3
CSF tau and the CSF tau/ABeta ratio for the diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).脑脊液tau蛋白及脑脊液tau蛋白与β淀粉样蛋白比值在轻度认知障碍(MCI)患者中用于诊断阿尔茨海默病性痴呆及其他痴呆。
Cochrane Database Syst Rev. 2017 Mar 22;3(3):CD010803. doi: 10.1002/14651858.CD010803.pub2.
4
Dual-catalytic hairpin amplification strategy as a highly efficient signal amplifier cooperative with COF@Au for ultrasensitive SERS detection of miRNA-21.双催化发夹扩增策略作为一种高效信号放大器,与COF@Au协同用于miRNA-21的超灵敏表面增强拉曼散射检测。
Anal Chim Acta. 2025 Oct 1;1369:344361. doi: 10.1016/j.aca.2025.344361. Epub 2025 Jun 23.
5
Cerebrospinal fluid phospho-tau T217 outperforms T181 as a biomarker for the differential diagnosis of Alzheimer's disease and PET amyloid-positive patient identification.脑脊液磷酸化tau蛋白T217在作为阿尔茨海默病鉴别诊断及PET淀粉样蛋白阳性患者识别的生物标志物方面优于T181。
Alzheimers Res Ther. 2020 Mar 17;12(1):26. doi: 10.1186/s13195-020-00596-4.
6
Plasma and cerebrospinal fluid amyloid beta for the diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).血浆和脑脊液β淀粉样蛋白用于诊断轻度认知障碍(MCI)患者的阿尔茨海默病性痴呆及其他痴呆。
Cochrane Database Syst Rev. 2014 Jun 10;2014(6):CD008782. doi: 10.1002/14651858.CD008782.pub4.
7
Anterior Approach Total Ankle Arthroplasty with Patient-Specific Cut Guides.使用患者特异性截骨导向器的前路全踝关节置换术。
JBJS Essent Surg Tech. 2025 Aug 15;15(3). doi: 10.2106/JBJS.ST.23.00027. eCollection 2025 Jul-Sep.
8
The Black Book of Psychotropic Dosing and Monitoring.《精神药物剂量与监测黑皮书》
Psychopharmacol Bull. 2024 Jul 8;54(3):8-59.
9
Self-reporting plasmonic nanoflowers enable magnetically enriched SERS immunoassay for ultrasensitive prostate cancer biomarker detection.自报告等离子体纳米花实现了磁富集表面增强拉曼散射免疫分析用于超灵敏前列腺癌生物标志物检测。
Biosens Bioelectron. 2025 Nov 15;288:117849. doi: 10.1016/j.bios.2025.117849. Epub 2025 Aug 6.
10
Systemic Inflammatory Response Syndrome全身炎症反应综合征

本文引用的文献

1
Revised criteria for diagnosis and staging of Alzheimer's disease: Alzheimer's Association Workgroup.修订的阿尔茨海默病诊断和分期标准:阿尔茨海默病协会工作组。
Alzheimers Dement. 2024 Aug;20(8):5143-5169. doi: 10.1002/alz.13859. Epub 2024 Jun 27.
2
Quercetin inhibits necroptosis in cardiomyocytes after ischemia-reperfusion via DNA-PKcs-SIRT5-orchestrated mitochondrial quality control.槲皮素通过 DNA-PKcs-SIRT5 调控的线粒体质量控制抑制缺血再灌注后心肌细胞的坏死性凋亡。
Phytother Res. 2024 May;38(5):2496-2517. doi: 10.1002/ptr.8177. Epub 2024 Mar 6.
3
Plasmonic silver and gold nanoparticles: shape- and structure-modulated plasmonic functionality for point-of-caring sensing, bio-imaging and medical therapy.
等离子体银和金纳米粒子:用于即时护理传感、生物成像和医学治疗的形状和结构调制等离子体功能。
Chem Soc Rev. 2024 Mar 18;53(6):2932-2971. doi: 10.1039/d3cs00793f.
4
Liquid-liquid phase separation in Alzheimer's disease.阿尔茨海默病中的液-液相分离
J Mol Med (Berl). 2024 Feb;102(2):167-181. doi: 10.1007/s00109-023-02407-3. Epub 2024 Jan 2.
5
New cyclophilin D inhibitor rescues mitochondrial and cognitive function in Alzheimer's disease.新型亲环素D抑制剂可挽救阿尔茨海默病中的线粒体和认知功能。
Brain. 2024 May 3;147(5):1710-1725. doi: 10.1093/brain/awad432.
6
Targeting tau in Alzheimer's disease: from mechanisms to clinical therapy.针对阿尔茨海默病中的tau蛋白:从机制到临床治疗
Neural Regen Res. 2024 Jul 1;19(7):1489-1498. doi: 10.4103/1673-5374.385847. Epub 2023 Sep 22.
7
Amyloid-beta and tau protein beyond Alzheimer's disease.阿尔茨海默病之外的β淀粉样蛋白和tau蛋白。
Neural Regen Res. 2024 Jun 1;19(6):1262-1276. doi: 10.4103/1673-5374.386406. Epub 2023 Oct 2.
8
Author Correction: Tau-targeting antisense oligonucleotide MAPT in mild Alzheimer's disease: a phase 1b, randomized, placebo-controlled trial.作者更正:针对轻度阿尔茨海默病的靶向tau反义寡核苷酸MAPT:一项1b期随机安慰剂对照试验。
Nat Med. 2024 Jan;30(1):304. doi: 10.1038/s41591-023-02639-3.
9
Neural stem cells promote neuroplasticity: a promising therapeutic strategy for the treatment of Alzheimer's disease.神经干细胞促进神经可塑性:一种治疗阿尔茨海默病的有前景的治疗策略。
Neural Regen Res. 2024 Mar;19(3):619-628. doi: 10.4103/1673-5374.380874.
10
Biomaterials-based anti-inflammatory treatment strategies for Alzheimer's disease.基于生物材料的阿尔茨海默病抗炎治疗策略
Neural Regen Res. 2024 Jan;19(1):100-115. doi: 10.4103/1673-5374.374137.